Biotechnology Industry

Members of Parliament invested in the Biotechnology Industry

35 investments

25 companies

Investors

Filed	Name	Company	Pur. £	Cur. £	P/L %	MPV*
Jun '22	Lord Sugar	Acl / NMS:ACLX	£17.47	£115.07	558.67%	£461,070.43
Mar '24	Lord Moynihan of Chelsea	Candel Therapeutics / NGM:CADL	£1.40	£6.20	342.86%	£309,999.99
May '22	Lord Reay	Novo Nordisk As / NYQ:NVO	£56.40	£140.80	149.67%	£174,767.27**
Mar '24	Lord Moynihan of Chelsea	Tg Therapeutics / NCM:TGTX	£15.05	£34.58	129.77%	£160,837.22
Mar '24	Lord Petitgas	Royalty Pharma / NMS:RPRX	£30.08	£49.54	64.69%	£115,285.91
May '22	Lord Triesman	Blue / NMS:BLUE	£3.39	£4.97	46.61%	£102,625.36
Jul '25	Lord Fink	Avacta Group / LSE:AVCT.L	£51.50	£73.60	42.91%	£100,038.83
Nov '21	Lord Sherbourne of Didsbury	Novo Nordisk As / NYQ:NVO	£56.71	£70.73	24.73%	£87,313.29**
Aug '23	Lord Nash	Relay / NGM:RLAY	£10.62	£13.03	22.69%	£85,885.12
Mar '24	Lord Moynihan of Chelsea	Fortress Biotech / NCM:FBIO	£1.92	£2.24	16.67%	£81,666.67
Apr '21	Baroness Deech	Novo Nordisk As / NYQ:NVO	£36.35	£41.17	13.26%	£79,281.98
Dec '22	Lord Hintze	Atai Life Sciences / NGM:ATAI	£3.48	£3.87	11.21%	£77,844.83**
Jun '16	Lord Lloyd-Webber	Bb Biotech / EBS:BION.SW	£47.80	£45.75	-4.29%	£66,997.91
Nov '24	Lord Moynihan of Chelsea	Sab Biotherapeutics / NCM:SABS	£3.95	£3.53	-10.63%	£62,556.96
Apr '22	Lord Hylton	Genus / LSE:GNS.L	£2,678.00	£2,304.00	-13.97%	£60,224.05
Mar '17	Lord Lloyd-Webber	Bb Biotech / EBS:BION.SW	£54.95	£45.75	-16.74%	£58,280.25
Mar '14	Lord Glendonbrook	Bb Biotech / EBS:BION.SW	£33.36	£27.20	-18.47%	£57,074.34**
Mar '24	Lord Moynihan of Chelsea	Mustang Bio / NCM:MBIO	£1.04	£0.75	-27.50%	£50,750.00
May '23	Lord Stevens of Ludgate	Avacta Group / LSE:AVCT.L	£112.00	£75.50	-32.59%	£47,187.50
Apr '24	Lord Grabiner	Novo Nordisk As / NYQ:NVO	£127.46	£64.73	-49.22%	£35,549.19**
Mar '24	Lord Petitgas	Moderna / NMS:MRNA	£111.98	£47.14	-57.90%	£29,467.76
Nov '23	Lord Mance	Novo Nordisk As / NYQ:NVO	£101.69	£41.17	-59.51%	£28,340.05
Apr '22	Lord Spencer of Alresford	Oxford Nanopore / LSE:ONT.L	£320.00	£112.60	-64.81%	£24,631.25
Apr '24	Lord Willoughby de Broke	Novo Nordisk As / NYQ:NVO	£122.75	£41.20	-66.44%	£23,494.91
Jan '21	Lord Spencer of Alresford	Immupharma / LSE:IMM.L	£12.65	£4.20	-66.80%	£23,241.11
May '24	Lord Londesborough	Novo Nordisk As / NYQ:NVO	£134.66	£41.17	-69.43%	£21,401.31
Oct '15	Lord Hayward	Sage / NGM:SAGE	£46.11	£8.68	-81.18%	£13,177.19
Sep '21	Lord Darzi of Denham	Oxford Nanopore / LSE:ONT.L	£612.60	£112.60	-81.62%	£12,866.47
May '11	Lord Glendonbrook	Mesoblast / NMS:MESO	£101.20	£15.22	-84.96%	£10,527.67
May '20	Lord Wolfson of Aspley Guise	Adc Therapeutics / NYQ:ADCT	£30.00	£3.76	-87.47%	£8,773.33
Apr '19	Lord Nash	Eq / NCM:EQ	£8.20	£0.69	-91.59%	£5,890.24**
Mar '24	Lord Moynihan of Chelsea	Avenue Therapeutics / NCM:ATXI	£12.00	£0.55	-95.42%	£3,208.33
Mar '23	Baroness Shields	Benevolentai / AMS:BAI.AS	£2.46	£0.09	-96.14%	£2,703.25**
Mar '24	Lord Moynihan of Chelsea	Adaptimmune / NMS:ADAP	£1.47	£0.03	-98.28%	£1,207.14**
Dec '22	Lord Hintze	Affimed / NGM:AFMD	£21.20	£0.18	-99.14%	£599.29

* Minimum Potential Value based on £70,000.00 invested at time of declaration.

** Interest ceased/exited on filed date.